HU195509B - Process for producing pyridinyl-piperazine derivatives and pharmaceutical compositions containing them as active agents - Google Patents

Process for producing pyridinyl-piperazine derivatives and pharmaceutical compositions containing them as active agents Download PDF

Info

Publication number
HU195509B
HU195509B HU861860A HU186086A HU195509B HU 195509 B HU195509 B HU 195509B HU 861860 A HU861860 A HU 861860A HU 186086 A HU186086 A HU 186086A HU 195509 B HU195509 B HU 195509B
Authority
HU
Hungary
Prior art keywords
formula
compounds
compound
acid
alkyl
Prior art date
Application number
HU861860A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT43848A (en
Inventor
James S New
P Joseph Yevich
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of HUT43848A publication Critical patent/HUT43848A/hu
Publication of HU195509B publication Critical patent/HU195509B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU861860A 1985-05-06 1986-05-06 Process for producing pyridinyl-piperazine derivatives and pharmaceutical compositions containing them as active agents HU195509B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73120185A 1985-05-06 1985-05-06

Publications (2)

Publication Number Publication Date
HUT43848A HUT43848A (en) 1987-12-28
HU195509B true HU195509B (en) 1988-05-30

Family

ID=24938510

Family Applications (1)

Application Number Title Priority Date Filing Date
HU861860A HU195509B (en) 1985-05-06 1986-05-06 Process for producing pyridinyl-piperazine derivatives and pharmaceutical compositions containing them as active agents

Country Status (25)

Country Link
JP (1) JPH0753728B2 (de)
KR (1) KR940000829B1 (de)
CN (1) CN1017901B (de)
AT (1) AT398572B (de)
AU (1) AU593244B2 (de)
BE (1) BE904724A (de)
CA (1) CA1278792C (de)
CH (1) CH672787A5 (de)
DE (1) DE3615180C2 (de)
DK (1) DK165745C (de)
EG (1) EG18206A (de)
ES (6) ES8801250A1 (de)
FI (1) FI85484C (de)
FR (1) FR2581385B1 (de)
GB (1) GB2174703B (de)
GR (1) GR861149B (de)
HU (1) HU195509B (de)
IE (1) IE59201B1 (de)
IT (1) IT1208607B (de)
LU (1) LU86421A1 (de)
MY (1) MY100777A (de)
NL (1) NL8601146A (de)
PT (1) PT82523B (de)
SE (1) SE465270B (de)
ZA (1) ZA862046B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801186A (en) 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
IE903410A1 (en) * 1989-10-09 1991-04-10 Novo Nordisk As Indole derivatives, their preparation and use
US5272148A (en) * 1992-09-09 1993-12-21 Hoechst-Roussel Pharmaceuticals Incorporated Heteroarenylpiperazines
FR2738824B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega(4-(thieno(3,2-c)pyridin-4-yl)piperazin-1 -yl)alkyl)-3,4-dihydroquinazolin-2(1h)-one,leur preparation et leur application en therapeutique
JP3335362B2 (ja) * 1995-09-15 2002-10-15 サノフィ―サンテラボ キノレイン−2(1h)−オン誘導体セロトニンアンタゴニスト
FR2738822B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 4-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)quinolein-2(1h)-one, leur preparation et leur application en therapeutique
FR2738823B1 (fr) * 1995-09-15 1997-10-31 Synthelabo Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique
FR2761071B1 (fr) * 1997-03-20 1999-12-03 Synthelabo Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2797874B1 (fr) * 1999-08-27 2002-03-29 Adir Nouveaux derives de la pyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines

Also Published As

Publication number Publication date
JPH0753728B2 (ja) 1995-06-07
GB2174703B (en) 1988-10-26
ES557757A0 (es) 1988-04-01
EG18206A (en) 1992-09-30
AU5679586A (en) 1986-11-13
ES557855A0 (es) 1989-05-16
DK165745C (da) 1993-06-14
ATA121486A (de) 1994-05-15
CH672787A5 (de) 1989-12-29
DE3615180C2 (de) 1996-03-07
IE861193L (en) 1986-11-06
DE3615180A1 (de) 1986-11-06
SE465270B (sv) 1991-08-19
KR940000829B1 (ko) 1994-02-02
DK207186A (da) 1986-11-07
ES8801250A1 (es) 1987-12-16
DK165745B (da) 1993-01-11
IT8620313A0 (it) 1986-05-06
FI861820A (fi) 1986-11-07
ES557839A0 (es) 1989-01-16
MY100777A (en) 1991-02-14
AU593244B2 (en) 1990-02-08
ZA862046B (en) 1986-11-26
IT1208607B (it) 1989-07-10
SE8602061D0 (sv) 1986-05-05
CN86103071A (zh) 1987-03-18
IE59201B1 (en) 1994-01-26
ES554659A0 (es) 1987-12-16
DK207186D0 (da) 1986-05-05
NL8601146A (nl) 1986-12-01
LU86421A1 (fr) 1986-12-05
HUT43848A (en) 1987-12-28
ES9000005A1 (es) 1989-11-01
FI85484B (fi) 1992-01-15
JPS61268681A (ja) 1986-11-28
ES8900138A1 (es) 1989-01-16
BE904724A (fr) 1986-11-05
PT82523A (en) 1986-06-01
ES8802149A1 (es) 1988-04-01
FR2581385A1 (fr) 1986-11-07
GR861149B (en) 1986-09-09
KR860009008A (ko) 1986-12-19
CN1017901B (zh) 1992-08-19
FI861820A0 (fi) 1986-04-30
CA1278792C (en) 1991-01-08
FR2581385B1 (fr) 1991-10-04
SE8602061L (sv) 1986-11-07
AT398572B (de) 1994-12-27
FI85484C (fi) 1992-04-27
ES8802614A1 (es) 1988-09-01
ES8900253A1 (es) 1989-05-16
PT82523B (pt) 1988-10-14
GB2174703A (en) 1986-11-12
ES557809A0 (es) 1988-09-01
GB8610810D0 (en) 1986-06-11

Similar Documents

Publication Publication Date Title
US5478934A (en) Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands
US5159083A (en) Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands
US5001130A (en) Psychotropic heterobicycloalkylpiperazine derivatives
JPS6084282A (ja) 1−ヘテロアリ−ル−4−〔(2.5−ピロリジンジオン−1−イル)アルキル〕ピペラジン誘導体
HU190997B (en) Process for preparing benzisothiazolyl-and benzisoxazolyl-piperazine derivatives
JPH054983A (ja) イソキノリノン誘導体、その製造方法およびその誘導体を有効成分として含有する5−ht3 レセプター拮抗剤
WO2007129111A1 (en) Diazepine derivatives as 5-ht2a antagonists
US6391891B1 (en) Bicyclic compounds as ligands for 5-HT1 receptors
HU195509B (en) Process for producing pyridinyl-piperazine derivatives and pharmaceutical compositions containing them as active agents
US4880930A (en) Psychotropic acyclic amide derivatives
US4677104A (en) Antipsychotic fused-ring pyridinylpiperazine derivatives
KR20010022658A (ko) 3-치환된 3,4,5,7-테트라히드로-피롤로[3'4':4,5]티에노[2,3-d]피리미딘 유도체, 그의 제법 및 5ht길항제로서의 용도
WO1996016057A1 (en) Certain 1-substituted aminomethyl imidazole and pyrrole derivatives; novel dopamine receptor subtype specific ligands
US5744472A (en) 1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands
US6436941B2 (en) 5,6-dihydro-napth[1,2-d]-imidazole, napth[1,2-d]imidazole, and chromane[3,4-d]imidazole derivatives
US6288230B1 (en) 2-(2, 3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands
JPH05247052A (ja) N−アルキルグルタールイミドの4−(4−ピペリジニル)−チエノ〔3,2−c〕ピリジン誘導体
US5773616A (en) Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
US5932729A (en) 1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands
JPH02200685A (ja) 新規なインドール誘導体
US5948912A (en) Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
US6002005A (en) Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands

Legal Events

Date Code Title Description
HU90 Patent valid on 900628